Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for anti-Pneumocystis jirovecii pneumonia (PcP) prophylaxis in kidney transplant recipients (KTR). Post-transplant management balances preventing PcP ...
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: G. V. Ramesh Prasad, Jill Beckley, Mohit Mathur, Madhushankar Gunasekaran, Michelle M. Nash, Lindita Rapi, Michael Huang and Jeffrey S. Zaltzman Tags: Research article Source Type: research
More News: Bactrim | Infectious Diseases | Kidney Transplant | Kidney Transplantation | Pneumonia | Sulfamethoxazole | Transplant Surgery | Transplants | Trimethoprim | Urology & Nephrology